Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

998 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene.
Ohta H, Uemura Y, Sone T, Tanaka S, Soen S, Mori S, Hagino H, Fukunaga M, Nakamura T, Orimo H, Shiraki M; Adequate Treatment of Osteoporosis (A-TOP) research group. Ohta H, et al. Among authors: uemura y. Calcif Tissue Int. 2023 Apr;112(4):430-439. doi: 10.1007/s00223-023-01060-9. Epub 2023 Jan 28. Calcif Tissue Int. 2023. PMID: 36707436 Free PMC article. Clinical Trial.
Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02.
Orimo H, Nakamura T, Fukunaga M, Ohta H, Hosoi T, Uemura Y, Kuroda T, Miyakawa N, Ohashi Y, Shiraki M; A-TOP (Adequate Treatment of Osteoporosis) research group. Orimo H, et al. Among authors: uemura y. Curr Med Res Opin. 2011 Jun;27(6):1273-84. doi: 10.1185/03007995.2011.580341. Epub 2011 May 10. Curr Med Res Opin. 2011. PMID: 21554143 Clinical Trial.
Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03).
Tanaka S, Miyazaki T, Uemura Y, Kuroda T, Miyakawa N, Nakamura T, Fukunaga M, Ohashi Y, Ohta H, Mori S, Hagino H, Hosoi T, Sugimoto T, Itoi E, Orimo H, Shiraki M. Tanaka S, et al. Among authors: uemura y. J Bone Miner Metab. 2014 May;32(3):298-304. doi: 10.1007/s00774-013-0491-4. Epub 2013 Jul 5. J Bone Miner Metab. 2014. PMID: 23828145 Clinical Trial.
Serum 25-hydroxyvitamin D level as an independent determinant of quality of life in osteoporosis with a high risk for fracture.
Ohta H, Uemura Y, Nakamura T, Fukunaga M, Ohashi Y, Hosoi T, Mori S, Sugimoto T, Itoi E, Orimo H, Shiraki M; Adequate Treatment of Osteoporosis (A-TOP) Research Group. Ohta H, et al. Among authors: uemura y. Clin Ther. 2014 Feb 1;36(2):225-35. doi: 10.1016/j.clinthera.2013.12.007. Epub 2014 Jan 22. Clin Ther. 2014. PMID: 24462224 Free article.
Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03.
Tanaka S, Miyazaki T, Uemura Y, Miyakawa N, Gorai I, Nakamura T, Fukunaga M, Ohashi Y, Ohta H, Mori S, Hagino H, Hosoi T, Sugimoto T, Itoi E, Orimo H, Shiraki M. Tanaka S, et al. Among authors: uemura y. J Bone Miner Metab. 2017 Jul;35(4):385-395. doi: 10.1007/s00774-016-0768-5. Epub 2016 Aug 2. J Bone Miner Metab. 2017. PMID: 27484436 Clinical Trial.
Study design of multi-center, open-label randomized controlled, head-to-head trial comparing minodronic acid and raloxifene: Japanese Osteoporosis Intervention Trial (JOINT)-04.
Uemura Y, Tanaka S, Miyazaki T, Tsukiyama M, Sone T, Taguchi A, Soen S, Mori S, Hagino H, Sugimoto T, Fukunaga M, Ohta H, Nakamura T, Orimo H, Shiraki M; Adequate Treatment of Osteoporosis (A-TOP) research group. Uemura Y, et al. J Bone Miner Metab. 2019 May;37(3):491-495. doi: 10.1007/s00774-018-0942-z. Epub 2018 Jul 17. J Bone Miner Metab. 2019. PMID: 30019249
Incidence of osteonecrosis of the jaw in Japanese osteoporosis patients taking minodronic acid.
Taguchi A, Uemura Y, Imai T, Tanaka S, Ohta H, Nakamura T, Orimo H, Sugimoto T, Soen S, Shiraki M; Adequate Treatment of Osteoporosis (A-TOP) research group. Taguchi A, et al. Among authors: uemura y. J Bone Miner Metab. 2019 Sep;37(5):886-892. doi: 10.1007/s00774-019-00990-5. Epub 2019 Feb 4. J Bone Miner Metab. 2019. PMID: 30719580 Clinical Trial.
Randomized head-to-head comparison of minodronic acid and raloxifene for fracture incidence in postmenopausal Japanese women: the Japanese Osteoporosis Intervention Trial (JOINT)-04.
Uemura Y, Sone T, Tanaka S, Miyazaki T, Tsukiyama M, Taguchi A, Soen S, Mori S, Hagino H, Sugimoto T, Fukunaga M, Ohta H, Nakamura T, Orimo H, Shiraki M; Adequate Treatment of Osteoporosis (A-TOP) Research Group. Uemura Y, et al. Curr Med Res Opin. 2020 Nov;36(11):1847-1859. doi: 10.1080/03007995.2020.1816537. Epub 2020 Sep 14. Curr Med Res Opin. 2020. PMID: 32870712 Clinical Trial.
998 results